These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 550786)
1. [Antagonism of angiotensin and vasopressin to the coronary vasodilating effect of verapamil and propafenon]. Cabral Ade M; de Oliveira AM; Futuro Neto Hde A Arq Bras Cardiol; 1979 Dec; 33(6):463-6. PubMed ID: 550786 [No Abstract] [Full Text] [Related]
2. [Changes in the mechanical action of the isolated guinea pig heart induced by doses of propafenon capable of affecting the electrocardiogram]. Tucci PJ; Cicogna AC; Spadaro J Arq Bras Cardiol; 1979 Sep; 33(3):229-32. PubMed ID: 543812 [No Abstract] [Full Text] [Related]
3. Effect of prostaglandin E 1 and E 2 on the vascular responsiveness to adrenaline, noradrenaline, angiotensin and vasopressin. Somova L Cor Vasa; 1972; 14(3):213-21. PubMed ID: 4344418 [No Abstract] [Full Text] [Related]
4. [Comparative studies on the effect of dipyridamole, oxyfedrine, ajmaline, propranolol and verapamil on the hypothermic fibrillation threshold of guinea pigs]. Kirsch U; Flick D; Autenrieth G; von Hymmen D Arzneimittelforschung; 1969 Apr; 19(4):654-6. PubMed ID: 5819168 [No Abstract] [Full Text] [Related]
5. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride]. Hapke HJ; Prigge E Arzneimittelforschung; 1976; 26(10):1849-57. PubMed ID: 1037204 [TBL] [Abstract][Full Text] [Related]
6. The effect of acute and chronic treatment of verapamil on pressor response to angiotensin II in rats. Lall SB; Kheterpal K; Rajdev S; Gupta YK Indian J Physiol Pharmacol; 1986; 30(2):145-8. PubMed ID: 3818041 [TBL] [Abstract][Full Text] [Related]
7. Calcium-entry blockade and pressor effect of angiotensin II in normal and nephrectomized rats. Iaina A; Goldfarb D; Kapuler S; Serban I; Gavendo S; Eliahou HE Isr J Med Sci; 1984 Mar; 20(3):207-10. PubMed ID: 6724865 [TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic characterization of propafenone in man]. Masini G; Dianda R; Masini M G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022 [TBL] [Abstract][Full Text] [Related]
9. [Comparative studies on the effects of oxyfedrine, epinephrine and digitalis glycosides on the function and high-energy phosphates of the guinea-pig heart]. Kammermeier H; Bünger R; Ziegler V; Gerlach E Arzneimittelforschung; 1974 Jun; 24(6):928-32. PubMed ID: 4408043 [No Abstract] [Full Text] [Related]
10. [Synergism and antagonism of some substances with angiotensin]. Lanza M; Richert J C R Seances Soc Biol Fil; 1969 May; 162(11):1969-71. PubMed ID: 4309267 [No Abstract] [Full Text] [Related]
11. Hemodynamic responses to vasopressin before and during infusion of sympathomimetic amines and angiotensin in anesthetized dogs. Fregnan GB Arzneimittelforschung; 1969 Mar; 19(3):354-6. PubMed ID: 4305821 [No Abstract] [Full Text] [Related]
12. [Effect of propafenon in myocardial refractoriness]. Mill JG Arq Bras Cardiol; 1981 Jan; 36(1):35-9. PubMed ID: 7271516 [No Abstract] [Full Text] [Related]
13. [Secondary depressive effect of propafenon on the low electric activity in isolated rabbit heart]. Barbosa HL; de Carvalho AP Arq Bras Cardiol; 1979 Dec; 33(6):459-62. PubMed ID: 550785 [No Abstract] [Full Text] [Related]
14. [Vasodilator effects of verapamil and propafenon]. Mill JG; Vassallo DV; Futuro Netto HA Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():7-10. PubMed ID: 678166 [No Abstract] [Full Text] [Related]
15. [Experimental analysis of some cardiovascular effects of Verapamil]. Marmo E; Coscia L; Rossi F; Chieppa S; Brita G; Caputi AP Minerva Med; 1975 May; 66(38):1771-826. PubMed ID: 1128822 [TBL] [Abstract][Full Text] [Related]
16. [Effect of propafenon on sinus node function]. Sant'Anna JR; Belardinelli L; Lucchese FA Arq Bras Cardiol; 1980 Jul; 35(1):15-8. PubMed ID: 7224885 [No Abstract] [Full Text] [Related]
17. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins. Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677 [TBL] [Abstract][Full Text] [Related]
18. [Effect of synthetic angiotensin on the intestine and search for its antagonists]. Irsakaeva AA; Kudrin AN Farmakol Toksikol; 1968; 31(4):447-50. PubMed ID: 4301580 [No Abstract] [Full Text] [Related]
19. [Prolonged administration of propafenon in the treatment of premature ventricular beats. Evaluation by dynamic (Holter) electrocardiography]. Rocha PJ; Albuquerque DC; Benchimol CB; Albanesi Filho FM; Magalhães ME; Schlesinger P; Benchimol AB Arq Bras Cardiol; 1980 Dec; 35(6):519-23. PubMed ID: 7259582 [No Abstract] [Full Text] [Related]
20. [Effect of ortho-(beta-diethylaminoethoxy)phenylpropiophenone x HCl (etafenone) on the dynamics, metabolism, O2-utilization and coronary flow of Heart]. Kukovetz WR Arzneimittelforschung; 1969 Oct; 19(10):1672-7. PubMed ID: 4391205 [No Abstract] [Full Text] [Related] [Next] [New Search]